Literature DB >> 23713740

Influence of plasma exchange on rituximab pharmacokinetics.

Nicolas Azzopardi1, Maud François, Emeline Laurent, Gilles Paintaud, Béatrice Birmelé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23713740      PMCID： PMC3769676          DOI： 10.1111/bcp.12167

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura.

Authors:  V McDonald; K Manns; I J Mackie; S J Machin; M A Scully
Journal:  J Thromb Haemost       Date:  2010-02-19       Impact factor: 5.824

2.  Evaluation of a peptide ELISA for the detection of rituximab in serum.

Authors:  H Blasco; G Lalmanach; E Godat; M C Maurel; S Canepa; M Belghazi; G Paintaud; D Degenne; E Chatelut; G Cartron; C Le Guellec
Journal:  J Immunol Methods       Date:  2007-07-17       Impact factor: 2.303

3.  Sequential blood level monitoring of basiliximab during multisession plasmapheresis in a kidney transplant recipient.

Authors:  M Nojima; T Yoshimoto; A Nakao; R Itahana; M Kyo; M Hashimoto; H Shima
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

4.  Rituximab therapy for acute humoral rejection after kidney transplantation.

Authors:  Stanislas Faguer; Nassim Kamar; Céline Guilbeaud-Frugier; Marylise Fort; Anne Modesto; Arnaud Mari; David Ribes; Olivier Cointault; Laurence Lavayssière; Joelle Guitard; Dominique Durand; Lionel Rostaing
Journal:  Transplantation       Date:  2007-05-15       Impact factor: 4.939

5.  Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.

Authors:  F Patriarca; M Medeot; M Isola; M L Battista; A Sperotto; C Pipan; E Toffoletti; M Dozzo; A Michelutti; G Gregoraci; A Geromin; M Cerno; C Savignano; C Rinaldi; F Barbone; R Fanin
Journal:  Transpl Infect Dis       Date:  2013-02-13       Impact factor: 2.228

Review 6.  B cell depletion in autoimmune disease.

Authors:  Claire Gorman; Maria Leandro; David Isenberg
Journal:  Arthritis Res Ther       Date:  2003-10-02       Impact factor: 5.156
  6 in total
  3 in total

1.  Cancer therapeutics revisited; novel drugs targeting cell signalling pathways, genome wide association studies and other trials and tribulations.

Authors:  Lionel D Lewis
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

Review 2.  Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.

Authors:  Sherif Hanafy Mahmoud; Jessica Buhler; Eric Chu; Suzie A Chen; Theresa Human
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

3.  Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.

Authors:  Marcus A Carden; Manila Gaddh; Abhinav Hoskote; Michael Brown; Virginia Merrill; Sean R Stowell; Shanmuganathan Chandrakasan; Ana Antun; Ragini Kudchadkar; Sarah Kotanchiyev; David L Jaye; Imre Bodó
Journal:  Blood Adv       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.